RAPT Therapeutics

IPO

Relentlessly focused on advancing treatments for patients with inflammatory and immunologic diseases

Public · San Francisco, United States · Founded 2015 · $497.0M raised

Employees
51–200
Founded
2015
Business Model
B2B
Website
rapt.com
Total Funding
$497.0M
Last Round
$250.0M Private EquityOct 2025
Rounds
4
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

RAPT Therapeutics is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing oral small molecule therapeutics that target key drivers of the immune system for inflammatory and immunologic diseases, including food allergy.

Summary

RAPT Therapeutics is a Biotech company based in San Francisco, United States, founded in 2015. It has raised $497.0M in total across 4 rounds, most recently a $250.0M Private Equity round in Oct 2025. Investors include GV.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Private EquityPrivate EquityOct 2025
$250.0M

Sign up to see all 7 events

Funding: Series C through Private Equity. Amounts, valuations, and investors where available.

Investors

Similar Companies

Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

RAPT Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/rapt-therapeutics"><img src="https://indexed.vc/api/badge/company/rapt-therapeutics" alt="RAPT Therapeutics on Indexed.vc" width="260" height="76" /></a>